Why the best CEOs make their first year both a personal transition and a profound moment of institutional renewal — with this quartet of skills.
Carolyn Dewar is a senior partner in McKinsey’s San Francisco office. She co-leads McKinsey’s CEO Excellence service line, and is co-author of A CEO for All Seasons.
Andrew Gazdecki — the founder and CEO of Acquire.com — explores the skillsets and pitfalls of selling a business. And why it’s often crucial to start all over again.
Tim Brinkhof is a Dutch-born, New York-based journalist reporting on art, history, and literature. He studied early Netherlandish painting and Slavic literature at New York University, worked as an editorial[…]
What happens when your boss decides to weaponize positivity in the workplace?
Mita Mallick is the author of Reimagine Inclusion and The Devil Emails at Midnight.
Airbnb’s CBO, Dave Stephenson, joins Big Think for a chat about elite-team leadership, “founder mode,” the Taylor Swift effect, and more.
Semyon Dukach — founding partner of VC firm One Way Ventures — adds balance to the founder mode debate.
Anne Chow, former CEO of AT&T Business, lays out a new approach to inclusive leadership that takes “thinking bigger” to the next level.
Three of the greatest moral philosophers — Bentham, Kant and Aristotle — offer invaluable and practical lessons for leaders today.
Want to get ahead? The best leaders are always humble, proactive and — above all — curious, advises Merlin CEO Jeremy Sirota.
Anne-Marie Rosser — CEO of creative agency VSA Partners — shares her cross-generational vision for a new brand of leadership.
Why Bob Stiller — founder and former CEO of billion-dollar beverage company Green Mountain Coffee Roasters — believes shared learnings are a win-win.
How to find the right balance between controlling teams and allowing them the agency to make mistakes — and learn from them.
By unlearning old leadership mindsets, cultures, and assumptions we can move from Industrial Age thinking to Intelligence Age thinking.
Benjamin Oakes — CEO of buzz-worthy biotech company Scribe Therapeutics — joins Big Think for a chat about innovation, human endeavor, and more.